Shareholder Returns

Returning Value to Shareholders

Taking account of strategic funding needs and earnings prospects, the Company aims for a consolidated dividend payout ratio of 45% on average in comparison with Core EPS to provide for a stable allocation of profit to all shareholders. In addition, internal reserves will be used to increase corporate value through investments to attain further growth in existing strategic domains and to identify future business opportunities.

Dividend History

Year Dividend (Yen per share) Payment Date (Y/M/D)
Interim Year-End Annual Interim Year-End
2020 75.00 25.00
(Forecast)
-* 2020/8/28 -
2019 48.00
  • Ordinary
    48.00
  • Special
    44.00
140.00 2019/8/30 2020/3/31
2018 31.00
  • Ordinary
    41.00
  • Special
    14.00
86.00 2018/8/31 2019/3/29
2017 29.00 33.00 62.00 2017/9/1 2018/3/23
2016 26.00 26.00 52.00 2016/9/1 2017/3/24
2015 26.00
  • Ordinary
    26.00
  • Special
    6.00
58.00 2015/9/1 2016/3/25
2014 22.00 26.00 48.00 2014/9/1 2015/3/27
2013 22.00 23.00 45.00 2013/8/30 2014/3/28
2012 20.00 20.00 40.00 2012/8/31 2013/3/28
2011 20.00 20.00 40.00 2011/9/1 2012/3/29

Shareholders of record on June 30 and December 31 are entitled to interim and year-end dividend payments, respectively.

  • *Effective July 1, 2020, Chugai Pharmaceutical Co., Ltd. (“Chugai”) has implemented a three-for-one stock split of its common stock. The dividend for the fiscal year ending December 31, 2020 presents the amount prior to the stock split for the end of the second quarter and the amount after the stock split for the end of the fiscal year. The annual dividends per share forecast is not stated because the amounts cannot be simply combined due to the implementation of the stock split. When calculated based on the assumption of no stock split, the year-end dividend is ¥75 and the annual dividend per share is ¥150.

Profit Distribution

Profit Distribution

Shareholder benefit program

Not applicable.

  • Like
  • Tweet
  • LINE it!
  • E-mail

Shareholder Information

Back to top